To investigate the regulatory role of the Orai1:STIM1 ratio on the activation of MEK/ERK signaling in pevonedistat-treated ALL cells, we examined the effects of down-regulating STIM1 on p-ERK1/2 activation by pevonedistat. This evidence concerns the gene STIM1 and acute lymphoblastic leukemia.